Pain Management

Pain medicine is being transformed by selective Nav1.8 sodium channel inhibition (suzetrigine/Journavx) for acute pain, expanded neuromodulation indications, and refined interventional techniques. The track will examine suzetrigine post-operative outcomes, low-dose ketamine infusions for refractory chronic pain and CRPS, and the maturation of dorsal root ganglion stimulation, closed-loop and high-frequency spinal cord stimulation, and peripheral nerve stimulation (Nalu, SPRINT). Interventional spine content covers cooled and conventional radiofrequency ablation for facet and SI joint pain, kyphoplasty, and minimally invasive SI joint fusion (iFuse, SI-Bone). Opioid stewardship, buprenorphine micro-induction, and cannabinoid evidence will be reviewed.